{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:10:36Z","timestamp":1759579836353},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":7251,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1008319618638","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"339-342","source":"Crossref","is-referenced-by-count":34,"title":["Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"F.","family":"Caponigro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cornelia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Budillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ionna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cornelia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008319618638_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jnci\/85.2.95","article-title":"Overview of combined modality therapies for head and neck cancer","volume":"85","author":"Dimery","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008319618638_bb0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08982109409037065","article-title":"Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth liposomes (Doxil)","volume":"4","author":"Working","year":"1994","journal-title":"J Liposom Res"},{"key":"10.1023\/A:1008319618638_bb0110","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","article-title":"Sterically stabilized liposomes: Improvement in pharmacokinetics and antitumor therapeutic efficacy","volume":"88","author":"Papahadjopoulos","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008319618638_bb0115","first-page":"3964","article-title":"Arrest of human lung tumor xenograft growth in SCID mice using doxorubicin encapsulated in sterically stabilised liposomes","volume":"53","author":"Williams","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008319618638_bb0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bjc.1996.193","article-title":"Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma","volume":"73","author":"Goebel","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008319618638_bb0125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008319618638_bb0130","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.1997.15.10.3185","article-title":"Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial","volume":"15","author":"Ranson","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008319618638_bb0135","first-page":"33","article-title":"The biodistnbution and pharmacokinetics of stealth liposomes in patients with solid tumors","volume":"10","author":"Stewart","year":"1997","journal-title":"Oncology"},{"key":"10.1023\/A:1008319618638_bb0140","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1995.13.7.1777","article-title":"Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies","volume":"13","author":"Uziely","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008319618638_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0005-2736(91)90162-2","article-title":"Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times","volume":"1070","author":"Lasic","year":"1991","journal-title":"Biochem Biophys Acta"},{"key":"10.1023\/A:1008319618638_bb0150","first-page":"10","article-title":"Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing HIV tat gene","volume":"143","author":"Huang","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008319618638_bb0155","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.1999.17.11.3512","article-title":"Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer","volume":"17","author":"Koukourakis","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008319618638_bb0160","series-title":"Results of a phase I\u2013II study. Proc Am Soc Clin Oncol","article-title":"Pegylated liposomal doxorubicin (Caelyx) in the treatment of advanced head and neck cancer","author":"Buntzel","year":"1999"},{"key":"10.1023\/A:1008319618638_bb0165","series-title":"Ann Oncol","article-title":"Phase II pilot study of Caelyx (doxorubicin HCL, pegylated liposomal) in patients with inoperable squamous-cell cancer of the head and neck (doxorubicin HCL, pegylated liposomal) in patients with inoperable squamous-cell cancer of the head and neck","author":"Stewart","year":"1998"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/3\/339\/19478382\/11-3-339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:39:01Z","timestamp":1582166341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420315295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0923753420315295"],"URL":"https:\/\/doi.org\/10.1023\/a:1008319618638","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}